TLRY Tilray Brands Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TLRY

Price (delayed)

$4.11

Market cap

$559.8M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.09

Enterprise value

$728.86M

?
Relative Growth: Rel. Growth: 75
Relative Strength: Rel. Strength: 8
Relative Valuation: Rel. Valuation: 32
Relative Profitability: Rel. Profitability: 35

Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients in eleven countries spanning five continents.

Highlights
The EPS has soared by 96% year-on-year and by 93% since the previous quarter
TLRY's net income has soared by 94% YoY and by 91% from the previous quarter
Tilray Brands's gross margin has decreased by 3.1% YoY but it has increased by 2.5% from the previous quarter
The debt has grown by 26% from the previous quarter and by 21% YoY
Tilray Brands's quick ratio has decreased by 21% from the previous quarter and by 13% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.tilray.com
Peers: OPK ORGO

Key stats

What are the main financial stats of TLRY

TLRY stock price

How has the Tilray Brands stock price performed over time
Intraday
-2.84%
1 week
4.58%
1 month
-15.08%
1 year
-66.85%
YTD
-54.49%
QTD
-8.46%

Financial performance

How have Tilray Brands's revenue and profit performed over time
Revenue
$915.45M
Gross profit
$260.44M
Operating income
-$78.03M
Net income
-$121.4M
Gross margin
28.4%
Net margin
-13.3%
The operating margin has soared by 97% YoY and by 95% from the previous quarter
The operating income has surged by 97% year-on-year and by 95% since the previous quarter
The net margin has soared by 95% YoY and by 92% from the previous quarter
TLRY's net income has soared by 94% YoY and by 91% from the previous quarter

Price vs fundamentals

How does TLRY's price correlate with its fundamentals

Growth

What is Tilray Brands's growth rate over time

Valuation

What is Tilray Brands stock price valuation
P/E
N/A
P/B
0.3
P/S
0.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.8
The EPS has soared by 96% year-on-year and by 93% since the previous quarter
The price to book (P/B) is 48% lower than the last 4 quarters average of 0.6 and 38% lower than the 5-year quarterly average of 0.5
TLRY's equity is up by 7% year-on-year and by 3.7% since the previous quarter
TLRY's price to sales (P/S) is 78% less than its 5-year quarterly average of 2.4 and 53% less than its last 4 quarters average of 1.1
TLRY's revenue is up by 11% year-on-year and by 7% since the previous quarter

Efficiency

How efficient is Tilray Brands business performance
The ROS has soared by 97% year-on-year and by 95% since the previous quarter
The ROIC has soared by 96% YoY and by 95% from the previous quarter
The company's return on equity has surged by 91% QoQ and by 90% YoY
The company's return on assets has surged by 91% QoQ and by 91% YoY

Dividends

What is TLRY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TLRY.

Financial health

How did Tilray Brands financials performed over time
The total liabilities has grown by 34% from the previous quarter and by 25% YoY
Tilray Brands's quick ratio has decreased by 21% from the previous quarter and by 13% YoY
The debt is 75% less than the equity
The debt has grown by 26% from the previous quarter and by 21% YoY
Tilray Brands's debt to equity has increased by 25% QoQ and by 14% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.